Theranostic advances and the role of molecular imprinting in disease management

Authors

Eylul Gulsen Yilmaz, B. Küçük, Yusuf Aslan, Özgecan Erdem, Yeşeren Saylan, Fatih Inci, Adil Denizli

Published

iScience 2025

DOI

10.1016/j.isci.2025.112186

Citations

11

Abstract

Summary Molecular imprinting has become an effective technology in the realm of diagnosing diseases, providing unparalleled specificity and sensitivity. This method is a promising trend in current medical research. This review examines the utilization of molecularly imprinted polymers (MIPs) in theranostic that integrates diagnostic functionalities for personalized medicine. The present work briefly discusses the fundamental concepts of molecular imprinting and how it has evolved into a versatile platform. Subsequently, the utilization of MIPs in the advancement of biosensors is focused, specifically emphasizing their contribution to the detection and diagnosis of diseases. The therapeutic potential of MIPs, focusing on targeted drug delivery and controlled release systems and the integration of MIPs into theranostic platforms is explored through case studies, showcasing the technology’s ability to simultaneously diagnose and treat diseases. Finally, we address the current challenges facing MIPs and discuss future perspectives, emphasizing the potential of this technology to revolutionize the next generation.

Cite this article

BibTeX

@article{eylul2025,
  title   = {Theranostic advances and the role of molecular imprinting in disease management},
  author  = {Eylul Gulsen Yilmaz and B. Küçük and Yusuf Aslan and Özgecan Erdem and Yeşeren Saylan and Fatih Inci and Adil Denizli},
  journal = {iScience},
  doi     = {10.1016/j.isci.2025.112186},
  year    = {2025}
}

← All publications DOI: 10.1016/j.isci.2025.112186